Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines

• Main Authors: Guy Cohen (Author), Pawornrath Jungsomsri (Author), Jirath Sangwongwanich (Author), Kriangkrai Tawinprai (Author), Taweegrit Siripongboonsitti (Author), Thachanun Porntharukchareon (Author), Kasiruck Wittayasak (Author), Nawarat Thonwirak (Author), Kamonwan Soonklang (Author), Gaidganok Sornsamdang (Author), Chirayu Auewarakul (Author), Nithi Mahanonda (Author)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Mass vaccination with a safe and effective vaccine may be the best way to control the COVID-19 pandemic. Heterologous prime-boost vaccination with the CoronaVac and AZD1222 vaccines may increase the immunogenicity elicited by either vaccine alone. This study sought to compare the immunogenicity of a...